Microbiota and probiotics: chances and challenges–a symposium report

CHS Ruxton, C Kajita, P Rocca, B Pot - Gut Microbiome, 2023 - cambridge.org
The 10th International Yakult Symposium was held in Milan, Italy, on 13–14 October 2022.
Two keynote lectures covered the crewed journey to space and its implications for the …

[HTML][HTML] Поражения органов пищеварения при постковидном синдроме. Клинические рекомендации

ВБ Гриневич, ЛБ Лазебник, ЮА Кравчук… - Экспериментальная …, 2022 - cyberleninka.ru
Термин «постковидный синдром» используется для обозначения долгосрочных
последствий перенесенной новой коронавирусной инфекции COVID-19, включающих …

[HTML][HTML] Genetic support of the causal association between gut microbiome and COVID-19: a bidirectional Mendelian randomization study

Z Li, G Zhu, X Lei, L Tang, G Kong, M Shen… - Frontiers in …, 2023 - frontiersin.org
Background The association between gut microbiome and coronavirus disease 2019
(COVID-19) has attracted much attention, but its causality remains unclear and requires …

[HTML][HTML] Predictive value of immunoglobulin G, activated partial thromboplastin time, platelet, and indirect bilirubin for delayed viral clearance in patients infected with …

L Zhang, S Xie, F Lyu, C Liu, C Li, W Liu, X Ma, J Zhou… - PeerJ, 2023 - peerj.com
Background Omicron is the recently emerged highly transmissible severe acute respiratory
syndrome coronavirus 2 variant that has caused a dramatic increase in coronavirus disease …

[PDF][PDF] RETRACTED: Microbiome-Based Hypothesis on Ivermectin's Mechanism in COVID-19: Ivermectin Feeds Bifidobacteria to Boost Immunity

S Hazan - Frontiers in Microbiology, 2022 - frontiersin.org
Ivermectin is an anti-parasitic agent that has gained attention as a potential COVID-19
therapeutic. It is a compound of the type Avermectin, which is a fermented by-product of …

[HTML][HTML] Efficacy of a Multistrain Synbiotic Treatment in Acute and Post-Acute COVID-19 Patients: A Double-Blind, Placebo-Controlled Randomized Trial

ML Giancola, A Fontana, C Panebianco… - …, 2024 - ncbi.nlm.nih.gov
Abstract Background and Aims: Several studies reported the effect of COVID-19 on inducing
gut dysbiosis, which is also correlated with disease severity. This study aims to investigate …

Gut microbiota: a potential influencer of insomnia occurring after COVID-19 infection

J Fang, S Wang, L Liu, X Zhang, R Liu, X Pang… - Frontiers in …, 2024 - frontiersin.org
The prevalence of insomnia has increased in recent years, significantly affecting the lives of
many individuals. Coronavirus disease 2019 (COVID-19) infection has been found to have a …

[HTML][HTML] Lactiplantibacillus plantarum KF511 ameliorates cigarette smoke extract and porcine pancreatic elastase-induced COPD via inhibition of MAPKs in mice

GD Kim, JE Eom, YI Kim, DU Shin, KM Lim… - Journal of Functional …, 2024 - Elsevier
Because diminished pulmonary function in chronic obstructive pulmonary disease (COPD)
is not fully reversible, it is important to prevent and manage COPD through smoking …

Efficacy of nutraceuticals (probiotics or prebiotics or synbiotics) in the prevention or treatment of COVID-19: a systematic review and meta-analysis

AP Sinha, MN Khatib, A Gaidhane… - Cogent Food & …, 2024 - Taylor & Francis
Nutraceuticals have generated an interest among clinicians for their applicability in the
prevention and treatment of many ailments. Literature suggests the possible role of …

[HTML][HTML] The Gut Microbiome of Children during the COVID-19 Pandemic

M Bacorn, HN Romero-Soto, S Levy, Q Chen… - Microorganisms, 2022 - mdpi.com
The gut microbiome has been shown to play a critical role in maintaining a healthy state.
Dysbiosis of the gut microbiome is involved in modulating disease severity and potentially …